These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26068730)

  • 1. Examining the relationship between health-related quality of life and increasing numbers of diagnoses.
    Barra M; Augestad LA; Whitehurst DG; Rand-Hendriksen K
    Qual Life Res; 2015 Dec; 24(12):2823-32. PubMed ID: 26068730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating health state utility values for comorbid health conditions using SF-6D data.
    Ara R; Brazier J
    Value Health; 2011; 14(5):740-5. PubMed ID: 21839413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating an EQ-5D-5L Value Set for China.
    Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
    Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard Comorbidity Measures Do Not Predict Patient-reported Outcomes 1 Year After Total Hip Arthroplasty.
    Greene ME; Rolfson O; Gordon M; Garellick G; Nemes S
    Clin Orthop Relat Res; 2015 Nov; 473(11):3370-9. PubMed ID: 25700999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
    Park SJ; Ahn S; Woo SJ; Park KH
    JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference weights for the spectrum of alcohol use in the U.S. Population.
    Chavez LJ; Bradley K; Tefft N; Liu CF; Hebert P; Devine B
    Drug Alcohol Depend; 2016 Apr; 161():206-13. PubMed ID: 26900145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
    Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health state utility instruments compared: inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D.
    Gamst-Klaussen T; Chen G; Lamu AN; Olsen JA
    Qual Life Res; 2016 Jul; 25(7):1667-78. PubMed ID: 26687615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Cancer-Specific Quality of Life and Health-Related Quality of Life in Young Adult Thyroid Cancer Survivors.
    Goldfarb M; Casillas J
    Thyroid; 2016 Jul; 26(7):923-32. PubMed ID: 27161396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
    Monroy M; Ruiz MA; Rejas J; Soto J
    Health Qual Life Outcomes; 2018 Sep; 16(1):177. PubMed ID: 30200982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.